BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7524764)

  • 21. Blocked ricin-conjugated T cell immunotoxins: effect of anti-CD6-blocked ricin on normal T cell function.
    Rasmussen RA; Counts SL; Lambert JM; Collinson AR
    Cancer Immunol Immunother; 1992; 35(5):355-63. PubMed ID: 1394340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the systemic toxicity and pharmacokinetics of the immunoconjugate anti-B4-blocked ricin in non-human primates. Delivered by multiple bolus injections and by continuous infusion.
    Shah SA; Lambert JM; Goldmacher VS; Esber HJ; Levin JL; Chungi V; Zutshi A; Braman GM; Ariniello PD; Taylor JA
    Int J Immunopharmacol; 1993 Aug; 15(6):723-36. PubMed ID: 7691767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-type-specific cytotoxicity of anti-CD4 and anti-CD8 ricin immunotoxins against human alloreactive T-cell clones.
    Uckun FM; Myers DE; Ledbetter JA; Wee SL; Vallera DA
    Blood; 1989 Nov; 74(7):2445-54. PubMed ID: 2572287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile.
    Papayannopoulou T; Brice M; Broudy VC; Zsebo KM
    Blood; 1991 Sep; 78(6):1403-12. PubMed ID: 1715789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells.
    Terstappen LW; Huang S; Safford M; Lansdorp PM; Loken MR
    Blood; 1991 Mar; 77(6):1218-27. PubMed ID: 1705833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.
    Snoeck HW; Lardon F; Lenjou M; Nys G; Van Bockstaele DR; Peetermans ME
    Exp Hematol; 1993 Oct; 21(11):1480-6. PubMed ID: 7691636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperthermia potentiates the activity of immunotoxin conjugates against common acute lymphoblastic leukaemia cells in vitro.
    Herrmann RP; Pelham JM; Raphael CL; Meyer BF; Davis RE
    Ann N Y Acad Sci; 1987; 511():428-35. PubMed ID: 2964219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the cell cycle status and primitive cell adhesion molecule profile of human CD34+ cells cultured in stroma-free versus porcine microvascular endothelial cell cultures.
    Chute JP; Saini AA; Kampen RL; Wells MR; Davis TA
    Exp Hematol; 1999 Feb; 27(2):370-9. PubMed ID: 10029177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of hematopoietic progenitor colony growth by a monoclonal antibody against the transferrin receptor: comparison of unconjugated antibody with an immunotoxin containing recombinant ricin A chain.
    Shannon KM; Ring DB; Houston LL; Schaffner V; Naylor J; Torkildson JC; Reid SA; Larrick J
    Int J Cell Cloning; 1990 Sep; 8(5):368-76. PubMed ID: 2230286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia.
    Turhan AG; Lemoine FM; Debert C; Bonnet ML; Baillou C; Picard F; Macintyre EA; Varet B
    Blood; 1995 Apr; 85(8):2154-61. PubMed ID: 7536493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
    Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C
    Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin.
    Wawrzynczak EJ; Watson GJ; Cumber AJ; Henry RV; Parnell GD; Rieber EP; Thorpe PE
    Cancer Immunol Immunother; 1991; 32(5):289-95. PubMed ID: 1998970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of a monoclonal antibody to plasma cells: a comparison with CD38 and PCA-1.
    Hata H; Matsuzaki H; Matsuno F; Sonoki T; Takemoto S; Kuribayashi N; Nagasaki A; Takatsuki K
    Clin Exp Immunol; 1994 May; 96(2):370-5. PubMed ID: 8187346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM; Gulati SC
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cells induce apoptosis of pre-B cells by interacting with bone marrow stromal cells.
    Tsujimoto T; Lisukov IA; Huang N; Mahmoud MS; Kawano MM
    Blood; 1996 Apr; 87(8):3375-83. PubMed ID: 8605355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Specific inhibition of in vitro lymphocyte transformation by an anti-pan T cell (gp67) ricin A chain immunotoxin.
    Kernan NA; Knowles RW; Burns MJ; Broxmeyer HE; Lu L; Lee HM; Kawahata RT; Scannon PJ; Dupont B
    J Immunol; 1984 Jul; 133(1):137-46. PubMed ID: 6609971
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinoic acid-induced CD38 antigen as a target for immunotoxin-mediated killing of leukemia cells.
    Mehta K; Ocanas L; Malavasi F; Marks JW; Rosenblum MG
    Mol Cancer Ther; 2004 Mar; 3(3):345-52. PubMed ID: 15026555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between in vivo toxicity and preclinical in vitro parameters for the immunotoxin anti-B4-blocked ricin.
    Grossbard ML; Lambert JM; Goldmacher VS; Blättler WA; Nadler LM
    Cancer Res; 1992 Aug; 52(15):4200-7. PubMed ID: 1379121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRAIL is a potent inducer of apoptosis in myeloma cells derived from multiple myeloma patients and is not cytotoxic to hematopoietic stem cells.
    Gazitt Y
    Leukemia; 1999 Nov; 13(11):1817-24. PubMed ID: 10557057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.